1938. Downregulation of acetyl-CoA synthetase 2 is a metabolic hallmark of tumor progression and aggressiveness in colorectal carcinoma.
Bae JM, Kim JH, Oh HJ, Park HE, Lee TH, Cho NY, Kang GH
Mod Pathol. 2017 Feb;30(2):267-277. doi: 10.1038/modpathol.2016.172. Epub 2016 Oct 7.Link
1937. Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers.
Kim KJ, Yang HK, Kim WH, Kang GH
Oncotarget. 2017 Jul 22;8(35):58887-58902. doi: 10.18632/oncotarget.19439. eCollection 2017 Aug 29.Link
1936. Clinicopathological and molecular implications of aberrant thyroid transcription factor-1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones.
Bae JM, Kim JH, Park JH, Park HE, Cho NY, Kang GH
Histopathology. 2018 Feb;72(3):423-432. doi: 10.1111/his.13398. Epub 2017 Dec 4.Link